Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation.
Nilay Sengul SamanciUmut YılmazSahin BedirNurgul Ozgur YurttasKerem OrucZehra Durak SahinEmir CelikKubra Nur ToplutasHilal AkıAhmet Emre EskazanFuat Hulusi DemirelliPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Our clinical knowledge with checkpoint inhibitors is increasing day by day, and to the best of our knowledge, this paper presents the first case in the English literature who developed follicular lymphoma after discontinuing nivolumab in non-small cell lung cancer patient.